Stay updated on Imvotamab in Non-Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Imvotamab in Non-Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Imvotamab in Non-Hodgkin Lymphoma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page has been updated to reflect the submission of results and has been revised to version 2.15.2.
    Difference
    0.2%
    Check dated 2025-05-01T06:25:13.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed descriptions of the imvotamab study and its mechanisms, while adding new information about the study's collaborators and a revision number update.
    Difference
    22%
    Check dated 2025-04-16T20:39:35.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T14:46:12.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2025-03-11T07:56:49.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-03-04T04:09:03.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    2%
    Check dated 2025-02-24T23:05:18.000Z thumbnail image

Stay in the know with updates to Imvotamab in Non-Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Imvotamab in Non-Hodgkin Lymphoma Clinical Trial page.